Seyed Reza Najafizadeh
Overview
Explore the profile of Seyed Reza Najafizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaboli M, Nakhjavani M, Rabizadeh S, Gholamzadeh M, Najafizadeh S
BMC Rheumatol
. 2025 Feb;
9(1):22.
PMID: 39994803
Background And Objective: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by synovial inflammation, cartilage, and bone destruction. Several studies have shown that leptin plays an important role in...
2.
Rostamian A, Aghayani S, Najafizadeh S, Saffarian Z, Yaseri M
Iran J Allergy Asthma Immunol
. 2025 Feb;
23(6):651-661.
PMID: 39985492
The exact cause of psoriatic arthritis is still unknown, but hypotheses suggest the role of hematological parameters in the onset and severity of the disease. This study evaluated the hematological...
3.
Bagheri L, Kavosi H, Shokouhi N, Aghayani S, Sadeghniiat Haghighi K, Najafizadeh S
Eur J Transl Myol
. 2024 Feb;
34(1).
PMID: 38351839
We aimed to investigate sleep disorders in patients with systemic scleroderma (SSc) and its relationship with socio-demographic and medical factors and to provide a suitable solution to better control the...
4.
Movassaghi S, SeyedAlinaghi S, Rostamian A, Najafizadeh S, Nezhadseifi E
Immun Inflamm Dis
. 2023 Jun;
11(6):e915.
PMID: 37382255
Introduction: Ankylosing spondylitis (AS) is a condition that is treated with nonsteroidal anti-inflammatory drugs and biological drugs such as anti tumor necrosis factor alpha (TNF-α). This study examined the prevalence...
5.
Abbasifard M, Khorramdelazad H, Rostamian A, Rezaian M, Saeed Askari P, Taghipur Khajeh Sharifi G, et al.
Trials
. 2023 Feb;
24(1):129.
PMID: 36810107
Backgrounds: N-acetylcysteine (NAC) has broadly been used as an anti-oxidant agent in various types of diseases. This study aimed to assess the effect of NAC on the systemic lupus erythematosus...
6.
Izadi S, Najafizadeh S, Nejati A, Teymoori-Rad M, Shahmahmoodi S, Shirazi F, et al.
Iran J Immunol
. 2021 Oct;
18(3):230-240.
PMID: 34596588
Background: Systemic lupus erythematous (SLE) is a multisystem autoimmune disorder. While studying the pathogenesis of SLE is prevalent, both infectious and non-infectious elements are regarded to exert an important impact...
7.
Ebrahimi M, Rostamian A, Rafiei-Latianee R, Najafizadeh S, Movaseghi S, Faezi S, et al.
Clin Rheumatol
. 2021 Sep;
41(2):533-539.
PMID: 34514533
Introduction: Dermatomyositis (DM) and polymyositis (PM) are known as two major types of idiopathic inflammatory myopathies (IMMs). During the past years, growing data strongly suggest the clinical significance of myositis-associated...
8.
Najafizadeh S, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M
Clin Rheumatol
. 2021 Jul;
40(10):4027.
PMID: 34195884
No abstract available.
9.
Najafizadeh S, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M
Clin Rheumatol
. 2021 May;
40(10):4019-4026.
PMID: 34050440
Background: Rheumatoid arthritis (RA) is a prevalent inflammatory disorder causing functional disabilities. Oxidative stress can cause inflammation and can also be induced by inflammation. Measuring oxidative stress markers could help...
10.
Laleh Far V, Najafizadeh S, Eslami M, Mollazadeh R
Eur Heart J
. 2020 Oct;
42(9):954.
PMID: 33106869
No abstract available.